Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population.

about

Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR)

P2860

Q58769009-3DD22136-1FEF-4B9B-9DB5-181728FB5456

P2860

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population.

Item

http://www.wikidata.org/entity/Q47691413

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Healthcare resource use and co ...... in the UK general population.

@en

Healthcare resource use and co ...... in the UK general population.

@nl

type

Item

label

Healthcare resource use and co ...... in the UK general population.

@en

Healthcare resource use and co ...... in the UK general population.

@nl

prefLabel

Healthcare resource use and co ...... in the UK general population.

@en

Healthcare resource use and co ...... in the UK general population.

@nl

P1476

Healthcare resource use and co ...... in the UK general population.

@en

P2093

Danny Gibson

http://www.w3.org/2001/XMLSchema#string

Elizabeth V Hillyer

http://www.w3.org/2001/XMLSchema#string

Joan B Soriano

http://www.w3.org/2001/XMLSchema#string

Marjan Kerkhof

http://www.w3.org/2001/XMLSchema#string

Sarowar Golam

http://www.w3.org/2001/XMLSchema#string

Trung N Tran

http://www.w3.org/2001/XMLSchema#string

P2860

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.

Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative.

Economic burden of asthma: a systematic review

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

Regression to the mean: what it is and how to deal with it.

Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.

Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma.

Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.

Development and validation of database indexes of asthma severity and control

P304

116-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THORAXJNL-2017-210531

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Price

P577

2017-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28918400

http://www.w3.org/2001/XMLSchema#string

P921

asthma

P932

5801646

http://www.w3.org/2001/XMLSchema#string

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population.

about

P2860

P2860

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932